跳至主要内容
临床试验/IRCT2017071535085N1
IRCT2017071535085N1招募中未知

Investigation the effects of palmitate and cichoric acid on inflammation pathway in PBMCs of type2 diabetic patient and control group

Hamadan University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 70 years(—)
性别
All

入选标准

  • FBS greater than 126 mg/dL; 2 hours blood glucose greater than 200 mg/dl; HbA1C greater than 6.5%; The control group should have a fasting blood glucose less than 100 mg/dl.
  • Exclusion criteria:
  • Use of medications such as antihypertensive drugs (such as beta-blockers), anti-diabetic drugs, estrogen supplements, thyroxine, diuretics and hypolipemic drugs; Other chronic and acute inflammatory diseases such as chronic kidney disease, cardiovascular disease, hypertension and ...; Infectious diseases, cancer, allergies; Other Endocrine Disorders (Except Type 2 Diabetes); Pregnancy; Smoking

排除标准

  • 未提供

研究者

相似试验